It is not clear if the exceedingly rare reports in the US — so far, six cases out of about 7 million inoculations — really are linked to the vaccine.But European regulators already have declared that the unusual type of clots are possibly linked to the AstraZeneca shot, which is made in a similar way and is in wide use around the globe, though not yet in the US.Still, experts agree COVID-19 poses a much larger risk of death and hospitalisation than the potential threat of atypical clots.
The European Medicines Agency, which approved the vaccine last month, has yet to react to its counterpart's move across the Atlantic. “But I think this vaccine must be used because it’s an important vaccine and the US decision was a precautionary one, and the choice of Johnson & Johnson to not immediately put it on the market in Europe was also a precautionary choice," Speranza said.
Under a contract with the European Commission, 200 million doses were supposed to arrive in the second quarter of this year. That deal allowed for the purchase an additional 200 million doses.
Wonderful news
I can't believe there's a blood clot.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »